ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    High Levels of Sars-cov-2 Detected in Immunosuppressed Covid-19 Patient Environments Weeks Following Initial Positive Test

    C. E. Kuschner1, Z. Brune2, L. B. Becker1, L. Teperman1

    1North Shore University Hospital, Manhasset, NY, 2Feinstein Institutes for Medical Research, Manhasset, NY

    *Purpose: COVID-19 is a novel viral illness associated with significantly worse mortality, prolonged disease course, and extended periods of viral shedding in transplant patients on…
  • 2021 American Transplant Congress

    Sars-cov-2 Stat Testing for Organ Donation; One Laboratory’s Experience

    S. Dionne, B. O'Neale

    VRL-Eurofins, Centennial, CO

    *Purpose: The COVID-19 pandemic took the U.S. by storm. The Transplant Community had to navigate through unprecedented scenarios in order to continue the life-saving mission…
  • 2021 American Transplant Congress

    Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Data from the US Scientific Registry of Transplant Recipients (SRTR)

    W. Fitzsimmons1, J. Erdman2, J. Wolfram3, D. Nimke2, R. Croy2, X. Wang2, T. Weaver4, D. Schladt4

    1University of Illinois at Chicago, College of Pharmacy, Vernon Hills, IL, 2Astellas Pharma, Inc, Northbrook, IL, 3Astellas Pharma Europe BV, Leiden, Netherlands, 4Chronic Disease Research Group, Minneapolis, MN

    *Purpose: There is currently no FDA approved immunosuppressive regimen for lung transplant (Tx) recipients; however, patients routinely receive a calcineurin inhibitor-based regimen. The SRTR database…
  • 2021 American Transplant Congress

    A Retrospective Analysis of the Safety and Efficacy of Apixaban After Lung Transplant

    T. Sam1, K. Reininger2, R. Patel1, C. Naik1, K. Ausloos1, R. Rosenblatt1, T. Grazia1, I. Lam3

    1Transplant, Baylor University Medical Center, Dallas, TX, 2Transplant, Hennepin County Medical Center, Minneapolis, MN, 3Transplant, Sharp Memorial Hospital, San Diego, CA

    *Purpose: Atrial arrhythmias and venous thromboembolism (VTE) are common after lung transplant. While direct acting oral anticoagulants (DOACs) have become anticoagulants of choice in atrial…
  • 2021 American Transplant Congress

    Short Term Outcomes in Previously Covid Positive Kidney Transplant Recipients in Pre-vaccine Era

    R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel

    Henry Ford Transplant Institute, Detroit, MI

    *Purpose: To study clinical characteristics and short-term outcomes in kidney transplant recipients who were previously infected with SARS-CoV-2*Methods: In this retrospective, single-center case-series, we identified…
  • 2021 American Transplant Congress

    Impact of a “COVID-free” Pathway on Living Donor Transplantation During a Pandemic

    S. Koganti, Y. Cheah, C. J. Simon, M. Tobon Lascano, J. Kim, M. E. Akoad

    Lahey Hospital & Medical Center, Burlington, MA

    *Purpose: COVID-19 pandemic has significantly decreased rates of organ transplantation, with most programs curtailing living donor transplantations. This has led to an increase in waitlist…
  • 2021 American Transplant Congress

    Solid Organ Transplant Telehealth Utilization Significantly Increased During the Covid-19 Pandemic: Experience at a Single, Large Volume Center

    R. Forbes, K. Kumm, H. O'Dell, K. Smith, L. Smith, A. Dreher, H. Schaefer, B. Concepcion

    Vanderbilt University Medical Center, Nashville, TN

    *Purpose: During the COVID-19 pandemic, telehealth utilization has allowed for the delivery of healthcare while protecting patients, caregivers, healthcare workers, and the community from exposure.…
  • 2021 American Transplant Congress

    Engineered Human Glomerular Endothelial Cells to Identify Non-hla Antibodies and Decipher Their Pathogenicity After Kidney Transplantation

    B. Lamarthée1, C. Burger1, C. Leclaire1, L. Morin1, F. Terzi1, C. Tinel1, D. Anglicheau2

    1Inserm U1151, Necker-Enfants Malades Institute, PARIS, France, 2Necker Hospital, AP-HP, Department of Nephrology and Kidney Transplantation, PARIS, France

    *Purpose: In kidney transplantation recipients (KTRs), donor-specific antibodies directed against Human Leucocyte Antigens (HLA-DSA) are thought to drive antibody-mediated rejection (AMR) and poor transplant outcome.…
  • 2021 American Transplant Congress

    Recovery After Extended Static Cold Storage Preservation Using Subnormothermic Machine Perfusion in VCA

    M. Goutard1, R. J. de Vries1, A. G. Lellouch1, E. Lupon1, C. Pendexter1, S. N. Tessier1, M. A. Randolph1, L. Lantieri2, C. L. Cetrulo1, K. Uygun1

    1Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA, 2Hôpital Européen Georges Pompidou, Paris, France

    *Purpose: Vascularized composite allografts (VCA) are more sensitive to cold ischemia than solid organ transplants due to the remaining metabolism in skeletal muscle cells. In…
  • 2021 American Transplant Congress

    A Multi-institutional Study of Renal Outcomes in Uterus Transplantation

    D. Sawinski1, L. Johannesson2, J. Kristen3, J. Fronek3, P. Porrett4

    1Hospital of the University of Pennsylvania, Philadelphia, PA, 2Department of Surgery, Baylor University Medical Center, Dallas, TX, 3Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 4University of Alabama at Birmingham, Birmingham, AL

    *Purpose: Pregnancy and calcineurin inhibitor-based immunosuppression represent potential renal stressors for uterus transplant (UTx) recipients, many of whom have Mayer-Rokitanksy-Kuster-Hauser (MRKH) syndrome and associated renal…
  • « Previous Page
  • 1
  • …
  • 235
  • 236
  • 237
  • 238
  • 239
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences